This trial aims to evaluate the effectiveness of a Behavioral Modification Working (BMW) Toolkit in improving glycemic control and blood pressure among pregnant women diagnosed with both GDM and PIH.
Pregnant women aged 15-49 years.
Gestational age between 16 and 20 weeks at enrolment.
Diagnosed with both gestational diabetes mellitus (GDM) and pregnancy-induced hypertension (PIH).
At least one prior antenatal visit at the study site.
Pre-existing diabetes mellitus or chronic hypertension prior to pregnancy.
Pre-existing renal disease, thyroid disease, or major hematological disorders.
Multiple pregnancy (e.g., twins, triplets).
Severe psychiatric illness.
Parallel
Behavioral Modification Working (BMW) Toolkit
BehavioralStructured behavioral intervention consisting of 7-8 sessions delivered by a trained health educator focusing on dietary modification, physical activity promotion, sleep hygiene, and self-care practices for pregnant women with gestational diabetes mellitus and pregnancy-induced hypertension, provided in addition to routine antenatal care.
Routine Antenatal Care
Other interventionStandard antenatal care provided according to hospital protocol for gestational diabetes mellitus and pregnancy-induced hypertension.
Fasting Blood Glucose
Fasting blood glucose concentration (mg/dL or mmol/L, according to site laboratory standard) will be measured at baseline and at follow-up. The outcome measure is the change from baseline to 40 weeks gestation, compared between study groups.
Blood Pressure
Systolic and diastolic blood pressure (mmHg) measured at baseline and follow-up. Outcome is change from baseline to 36 weeks gestation compared between study groups.
Click on the lead sponsor to view all of their trials.
